JEITO CAPITAL
Jeito Capital is a private equity general partner firm headquartered in Paris, France.
JEITO CAPITAL
Industry:
Venture Capital
Founded:
2018-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium
Similar Organizations
Endure Capital
Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams.
Current Employees Featured
Rafaele Tordjman Founder & CEO @ Jeito Capital
Founder & CEO
2017-04-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-13 | CDR-Life AG | Jeito Capital investment in Series A - CDR-Life AG | 76 M USD |
| 2022-03-16 | Precirix | Jeito Capital investment in Series B - Precirix | 80 M EUR |
| 2022-02-22 | Eyebiotech | Jeito Capital investment in Series A - Eyebiotech | 65 M USD |
| 2022-02-15 | NMD Pharma | Jeito Capital investment in Venture Round - NMD Pharma | 35 M EUR |
| 2021-11-29 | Quell Therapeutics | Jeito Capital investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-06-15 | Alentis Therapeutics | Jeito Capital investment in Series B - Alentis Therapeutics | 60 M CHF |
| 2021-05-27 | Pulmocide | Jeito Capital investment in Series C - Pulmocide | 92 M USD |
| 2020-12-14 | Innoskel | Jeito Capital investment in Series A - Innoskel | 20 M EUR |
| 2020-10-21 | SparingVision | Jeito Capital investment in Venture Round - SparingVision | 44.5 M EUR |
| 2020-09-14 | Neogene Therapeutics | Jeito Capital investment in Series A - Neogene Therapeutics | 110 M USD |
More informations about "Jeito Capital"
Jeito
Jeito Capital est basé à Paris avec une présence en Europe et aux Etats-Unis. En savoir plus. En bref. Nos dernières actualités. Jeito Capital annonce un financement significatif au sein du tour de 187 millions de dollars de Callio Therapeutics pour assurer le développement de conjugués …See details»
A focus on patient benefits - Jeito
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation. Jeito empowers and supports …See details»
The team - Jeito
Ksenija Pavletic is a Partner and Chief Commercial Officer (“CCO”) at Jeito Capital with over 25 years’ experience in pharma & biotech. She is an expert in both investment strategies and healthcare companies scaleups with a …See details»
Jeito Capital - Crunchbase Investor Profile & Investments
Jeito Capital is a global investment company that invests in companies in the field of medical innovation. It focuses both on financing ground-breaking medical …See details»
Jeito Capital announces significant participation in $187 million ...
Paris, March 3 rd 2025 – Jeito Capital (“Jeito”), a global leading independent Private Equity fund dedicated to biopharma, announced today its significant participation in the $187 million …See details»
Jeito Capital Investor Information - Funding, Portfolio Companies, …
Jeito Capital is a venture capital fund based in Paris, with a presence in Europe and the US. They invest in Series B stages, focusing on biotech and pharma companies. Jeito Capital supports …See details»
Jeito Capital - Funding, Financials, Valuation & Investors
Jeito Capital has raised 2 funds, their latest being Jeito I. This fund was announced on Sep 20, 2021 and raised a total of . obfuscated. obfuscated. Unlock for free . Funds Raised. Edit Funds …See details»
Jeito Capital announces significant participation in $187 million ...
Paris, March 3 rd 2025 – Jeito Capital (“Jeito”), a global leading independent Private Equity fund dedicated to biopharma, announced today its significant participation in the $187 million ...See details»
Société JEITO CAPITAL : Chiffre d'affaires, statuts, extrait d ...
2 days ago « JEITO CAPITAL », SAS au capital de 250.000,00 €, siège social : 124/126 rue de Provence 75008 Paris, 839 611 449 R.C.S. Paris. Suivant procès-verbal des décisions du …See details»
WuXi AppTec's Subsidiary Invests EUR 20 Million in Jeito II S.L.P.
Dec 9, 2024 China-based Contract Development and Manufacturing Organization (CDMO) WuXi AppTec Co., Ltd (SHA: 603259) has announced that its wholly owned subsidiary, WuXi …See details»
Jeito Capital - Contacts, Employees, Board Members ... - Crunchbase
Jeito Capital is a global investment company that invests in companies in the field of medical innovation.See details»
JEITO - LinkedIn
JEITO | 7 264 abonnés sur LinkedIn. Go faster for the Patient, further with the Entrepreneur | Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing …See details»
Our portfolio - Jeito
Jeito Capital is building a strong and diversified portfolio in Biopharma and innovative medical companies. Neogene Therapeutics Oncology - Cell Therapy. ... Jeito chooses CDR-Life as its …See details»
Sanofi-backed Jeito Capital closes $630M fund to finance 12-15 …
Sep 20, 2021 After gaining high-profile backing from Sanofi last November, French venture firm Jeito Capital has pulled together more partners to close its first fund at 534 million euros ($630 …See details»
French PE fund Jeito Capital invests in global biopharma growth …
Jan 7, 2025 Paris-based Jeito Capital, a PE fund focused on biopharma innovation, has furthered its position as a player in global healthcare investment with two major contributions …See details»
Jeito s'engage au sein d'une biotech singapourienne | CFNEWS
Mar 4, 2025 JEITO CAPITAL . Julien Elric . CALLIO THERAPEUTICS . Opération(s) liée(s) : Capital Innovation CALLIO THERAPEUTICS 03/03/25 12:00. CFNEWS Newsletter. Tous les …See details»
Jeito Capital announces significant participation in $187 million ...
Mar 3, 2025 Jeito Capital announces significant participation in $187 million Series A financing for Callio Therapeutics to ... 2025-03-03, 14:47, Nasdaq Globe Newswire Headlines WN.com - …See details»
Jeito Capital | Globenewswire
Paris, March 3 rd 2025 – Jeito Capital (“Jeito”), a global leading independent Private Equity fund dedicated to biopharma, announced today its significant participation in the $187 million …See details»
Jeito Capital renforce et structure son équipe pour soutenir sa ...
Paris, France, 26 octobre 2022 – Jeito Capital (« Jeito »), société de capital-investissement internationale et indépendante de premier plan, spécialisée dans le domaine de la Biopharma, …See details»
Trump Organization accuses ‘woke’ Capital One of de-banking
Mar 10, 2025 The Trump Organization and Eric Trump had been clients of Capital One for decades, holding millions of dollars at the bank, the lawsuit noted. But on March 8, 2021, …See details»